-Suppression of tumor growth, metastasis to lymph nodes and lungs, and angiogenesis in vivo -Targeting ephrin-A2 may decrease prostate cancer metastasis by targeting EMT-related markers. This evidence concerns the gene EFNA2 and prostate carcinoma.